Fisher syndrome as an immune-related adverse event after using pembrolizumab but not nivolumab

Authors :: Akira Tamaoka
Toshikazu Moriwaki
Sho Okune
Takeshi Yamada
Kiyotaka Nakamagoe
Source :: Acta Neurologica Belgica. 121:1381-1382
Publication Year :: 2021
Publisher :: Springer Science and Business Media LLC, 2021.

Subjects :: Oncology
medicine.medical_specialty
Neurology
business.industry
Fisher Syndrome
General Medicine
Pembrolizumab
Immune system
Internal medicine
medicine
Neurology (clinical)
Nivolumab
Adverse effect
business
Neuroradiology

Tools